Clinical Trial: Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Drug Use Investigation of Julina Tablets 0.5 mg (Postmenopausal Osteoporosis)

Brief Summary: This study is a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Julina for postmenopausal osteoporosis. The objective of this study is to assess safety and efficacy of using Julina in clinical practice. A total 100 patients will be recruited and followed 3 years since starting Julina administration.